Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
08/2014
08/26/2014US8816079 Amide derivative and use thereof as medicine
08/26/2014US8815928 Hepatitis C virus inhibitors
08/26/2014US8815927 Bivalent diazo bicyclic Smac mimetics and the uses thereof
08/26/2014US8815905 Propionic acids, propionic acid esters, and related compounds
08/26/2014US8815885 Methods and compositions for modulating IRE1, SRC, and ABL activity
08/26/2014US8815878 Spiro hemiaminals for treating viral diseases
08/26/2014US8815877 Serine/threonine kinase inhibitors
08/26/2014US8815871 N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
08/26/2014US8815869 Lactam acetamides as calcium channel blockers
08/26/2014US8815867 Inhibitors of c-fms kinase
08/26/2014US8815864 Indanyloxydihydrobenzofuranylacetic acids
08/26/2014US8815861 N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors
08/26/2014US8815855 N-sulphonylpyrroles and their use as histone deacetylase inhibitors
08/26/2014US8815845 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
08/26/2014US8815840 Carbazole and carboline kinase inhibitors
08/26/2014US8815839 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
08/26/2014US8815418 Compound including fluorenyl group for organic photoelectric device and organic photoelectric device including the same
08/26/2014US8815412 Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic appliance using the quinoxaline derivative
08/26/2014CA2656618C Cyclopenta [d] pyrimidines as akt protein kinase inhibitors
08/21/2014WO2014127315A1 Centrally active and orally bioavailable antidotes for organophosphate exposure and methods for making and using them
08/21/2014WO2014126954A1 Regioselective synthesis of substituted pyrimidines
08/21/2014WO2014126596A1 Neuroprotective multifunctional antioxidants and their monofunctional analogs
08/21/2014WO2014125444A1 Heterocyclic amides as kinase inhibitors
08/21/2014WO2014124850A1 Substituted [1,2,4]triazole and imidazole compounds
08/21/2014WO2014124651A1 Pyrrolidine-2-carboxylic acid derivatives as iglur antagonists
08/21/2014WO2014100620A3 Compounds and methods for kinase modulation, and indications therefor
08/21/2014WO2014096388A3 Novel benzimidazole derivatives as kinase inhibitors
08/21/2014WO2014070888A8 Organic conductive materials and devices
08/21/2014US20140235858 Neuroprotective multifunctional antioxidants and their monofunctional analogs
08/21/2014US20140235657 Therapeutic compounds and uses thereof
08/21/2014US20140235654 Use of derivatives of indoles for the treatment of cancer
08/21/2014US20140235653 Hydrazide containing nuclear transport modulators and uses thereof
08/21/2014US20140235640 Novel Dihydropyrimidin-2(1H)-one Compounds as S-Nitrosoglutathione Reductase Inhibitors
08/21/2014US20140235638 Anti-Infective Agents and Uses Thereof
08/21/2014US20140235622 Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
08/21/2014US20140235613 Substituted diaryl azetidine derivatives as sphingosine receptor modulators
08/21/2014US20140235606 Crystalline forms of n-[2-[[(2,3-difluorophenyl)methyl]thio]-6--4-pyrimidinyl]-1-azetidinesulfonamide
08/21/2014US20140234939 Benzamide Compounds and Related Methods of Use
08/21/2014US20140234376 Substituted Benzoazepines as Toll-Like Receptor Modulators
08/21/2014US20140234333 Compositions and methods for inhibition of the jak pathway
08/20/2014EP2766357A2 Meso-biliverdin compositions and methods
08/20/2014EP2766356A1 Quinazoline derivatives as kinases inhibitors and methods of use thereof
08/20/2014EP2766355A2 Pyrazol-3-ones that activate pro-apoptotic bax
08/20/2014EP2766354A1 Protein kinase inhibitors
08/20/2014EP2766352A1 Indazole compounds as kinase inhibitors and method of treating cancer with same
08/20/2014EP2766345A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
08/19/2014US8809549 Esters of bendamustine and related compounds, and medical use thereof
08/19/2014US8809548 Hepatitis C virus inhibitors
08/19/2014US8809538 Piperidine-containing compounds and use thereof
08/19/2014US8809525 1,2,4-triazine-4-amine derivatives
08/19/2014US8809382 5-oxo-ETE receptor antagonist compounds
08/19/2014US8809364 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors
08/19/2014US8809339 Compounds and methods for inhibiting phosphate transport
08/19/2014US8809333 Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
08/19/2014US8809326 Isoquinolinone Rho kinase inhibitors
08/19/2014US8809323 Therapeutic applications of pro-apoptotic benzodiazepines
08/19/2014US8809313 Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
08/19/2014US8809264 Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors
08/19/2014CA2724629C Tetrahydrocyclopenta[b]indole androgen receptor modulators
08/19/2014CA2608367C Compositions and methods for inhibition of the jak pathway
08/14/2014WO2014123238A1 Organic light-emitting device
08/14/2014WO2014122160A1 Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
08/14/2014WO2014121931A1 Pyridazinone-amides derivatives
08/14/2014WO2014121383A1 A process for the preparation of rufinamide and intermediates thereof
08/14/2014WO2014097151A3 Autotaxin inhibitors
08/14/2014WO2014090396A3 Use of maleimide derivatives for preventing and treating cancer
08/14/2014US20140228566 Quinoxaline Derivative, and Light Emitting Element, Light Emitting Device, and Electronic Device Using the Quinoxaline Derivative
08/14/2014US20140228383 Process for the production of moxonidine
08/14/2014US20140228378 N-(Benzimimdazol-2-yl)-Cyclopropane Carboxamides as Lysophosphatidic Acid Antagonists
08/14/2014US20140228371 Quinoline and quinazoline amides as modulators of sodium channels
08/14/2014US20140228367 Preparation and methods of use for ortho-aryl 5-membered heteroaryl-carboxamide containing multi-targeted kinase inhibitors
08/14/2014US20140228362 Method of Treatment or Prophylaxis
08/14/2014US20140228361 Aminoquinazoline derivatives and their salts and methods of use
08/14/2014US20140228360 Prmt5 inhibitors and uses thereof
08/14/2014US20140228359 Bis-indolic derivatives, their uses in particular as antibacterials
08/14/2014US20140228358 Acyclic cyanoethylpyrazoles as janus kinase inhibitors
08/14/2014US20140228354 Method for Inhibition of Deubiquitinating Activity
08/14/2014US20140228351 Substituted indazole derivatives active as kinase inhibitors
08/14/2014US20140228348 Cyanomethylpyrazole carboxamides as janus kinase inhibitors
08/14/2014US20140228339 Novel Compound
08/14/2014US20140228338 Topical ocular analgesic agents
08/14/2014US20140225097 Stilbene Derivatives, Light-Emitting Element, Display Device, and Electronic Device
08/13/2014EP2765131A1 Process for the production of Moxonidine
08/13/2014EP2763994A2 Novel quinoxaline inhibitors of pi3k
08/13/2014EP2763984A1 1-pyrazolyl-3- (4- ( (2 -anilinopyrimidin- 4 - yl) oxy) napththalen- 1 - yl) ureas as p38 map kinase inhibitors
08/13/2014EP2763983A1 L-pyrazolyl-3- (4- ( (2 -anilinopyrimidin- 4 - yl) oxy) napththalen- 1 - yl) ureas as p3i map kinase inhibitors
08/13/2014EP2763977A1 Ethynyl derivatives as mglur5 allosteric modulators
08/13/2014CN103987708A 4-羟基-1,2,3,4-四氢萘-1-基脲的衍生物和它们在呼吸道疾病以及其它疾病的治疗中的用途 4-hydroxy-1,2,3,4-tetrahydro-naphthalen-1-yl urea derivatives and their use in the treatment of respiratory diseases and other diseases in the
08/13/2014CN103987707A 吡唑-4-基-杂环基-甲酰胺化合物以及使用方法 Pyrazol-4-yl - heterocyclyl - carboxamide compound, and use of
08/13/2014CN103987701A N-(1,2,5-噁二唑-3-基)-、n-(1,3,4-噁二唑-2-基)-、n-(四唑-5-基)-和n-(三唑-5-基)-芳基甲酰胺及其作为除草剂的用途 N- (1,2,5- oxadiazol-3-yl) -, n- (1,3,4- oxadiazol-2-yl) -, n- (tetrazol-5-yl) - and n- (triazol-5-yl) - aryl carboxamide and their use as herbicides
08/13/2014CN103987699A 作为pi3k调节剂的喹唑啉衍生物 As quinazoline derivatives pi3k moderator
08/13/2014CN103987698A 作为激酶lrrk2调节剂用于治疗帕金森病的2-苯基氨基嘧啶衍生物 Amino-pyrimidine derivatives as kinase lrrk2 modifier used to treat Parkinson's disease 2-phenyl
08/13/2014CN103987697A 作为因子xia抑制剂的取代的四氢异喹啉化合物 As the substituted tetrahydroisoquinoline compounds factor inhibitors xia
08/13/2014CN103987694A 具有7-氨基-1,2,3,4-四氢喹啉结构的成色剂、包含它们的染色组合物、方法及用途 With a 7-amino-1,2,3,4-tetrahydroquinoline structure coupler, the dyeing compositions containing them, methods, and uses
08/13/2014CN103980256A 一种新型双氮氧自由基的制备方法及结构表征 Preparation of a new dual nitroxides and Characterization
08/13/2014CN103980255A 一种双苯并咪唑衍生物紫外线吸收剂及其制备方法 A dual-benzimidazole derivatives and preparation method thereof ultraviolet absorber
08/13/2014CN103980254A 一种有机电致发光化合物 An organic electroluminescent compounds
08/13/2014CN103980253A 一种5-氯-6-(2-亚氨基吡咯烷基-1-基)甲基-2,4-(1h, 3h)嘧啶二酮盐酸盐的合成方法 A crystal of 5- chloro-6- (2-imino-1-pyrrolidinyl) methyl -2,4- (1h, 3h) synthesis -pyrimidinedione hydrochloride
08/13/2014CN103980252A 制备含1,2,4-三氮唑的吡唑类席夫碱治疗肿瘤的药物 Pyrazoles drug treatment of tumors Schiff bases containing 1,2,4-triazole preparation of
08/13/2014CN103977406A 抗病毒化合物 Antiviral compounds
1 ... 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ... 626